Site# 433 — San Antonio, Texas

Site# 433 is a clinical research site located in San Antonio, Texas, United States 78215.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Site# 433 has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Nonalcoholic Steatohepatitis (NASH), Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis, Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD).

Sponsors: Corcept Therapeutics.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in San Antonio

Browse all research sites in Texas · View every site in San Antonio

• The University of Texas San Antonio
• Children's Hospital of San Antonio
• University Health-University Hospital
• Methodist Healthcare System of San Antonio, Methodist Hospital, Methodist Children's Hospital
• Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio
• San Antonio Community Hospital
• Dialysis West University Health System
• 840-02 - The University of Texas Health Science Center
• University Hospital /Univ of Texas Health Science Center
• University of Texas Health San Antonio and University Health System
• University Health Center Downtown
• University Of Texas Health San Antonio (UTHSA)- University Health

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site# 433?

Site# 433 has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site# 433 conducted?

Site# 433 has 2 clinical trials on record, with 2 currently active. Their work covers Nonalcoholic Steatohepatitis (NASH), Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis, Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD).

Is Site# 433 accredited by Crixeo Clinical Trials?

Site# 433 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site# 433?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.